Cellular Mechanisms Underlying the Cardioprotective Role of Allicin on Cardiovascular Diseases
Related Experiment Video
Updated: Aug 30, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
José L Sánchez-Gloria1,2, Abraham S Arellano-Buendía3, Juan G Juárez-Rojas4
1Sección de Estudios de Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Insights
Allicin, a garlic compound, shows potential for treating cardiovascular diseases (CVDs) by modulating cellular mechanisms. This review explores its therapeutic effects on CVD risk factors.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiology
Background:
- Cardiovascular diseases (CVDs) involve complex, multifactorial origins affecting blood vessels, heart tissue, and rhythm.
- Current CVD management relies on multidisciplinary approaches and multiple drugs to control risk factors like dyslipidemia, hypertension, and inflammation.
- Existing pharmacological treatments for CVDs and their risk factors are limited or not fully established in clinical practice.
Purpose of the Study:
- To review the cellular mechanisms underlying allicin's therapeutic effects.
- To evaluate allicin's potential as a therapeutic option for CVD prevention and treatment.
- To highlight allicin's impact on key cardiovascular risk factors.
Main Methods:
- Literature review of studies on allicin and cardiovascular health.
- Analysis of cellular mechanisms and signaling pathways affected by allicin.
- Synthesis of evidence regarding allicin's effects on cardiovascular risk factors.
Main Results:
- Allicin, a sulfur compound from garlic, demonstrates beneficial effects on multiple cardiovascular risk factors.
- Allicin modulates key cellular mechanisms and signaling pathways relevant to CVD.
- Evidence suggests allicin's role in mitigating dyslipidemia, hypertension, oxidative stress, and inflammation.
Conclusions:
- Allicin exhibits significant therapeutic potential for cardiovascular diseases and their associated risk factors.
- Understanding allicin's cellular actions provides a basis for its development as a novel CVD therapeutic agent.
- Further research is warranted to translate these findings into clinical applications for cardiovascular health.
Abstract:
Cardiovascular diseases (CVDs) are a group of diseases in which the common denominator is the affection of blood vessels, heart tissue, and heart rhythm. The genesis of CVD is complex and multifactorial; therefore, approaches are often based on multidisciplinary management and more than one drug is used to achieve the optimal control of risk factors (dyslipidemia, hypertension, hypertrophy, oxidative stress, endothelial dysfunction, inflammation). In this context, allicin, a sulfur compound naturally derived from garlic, has shown beneficial effects on several cardiovascular risk factors through the modulation of cellular mechanisms and signaling pathways. Effective pharmacological treatments for CVD or its risk factors have not been developed or are unknown in clinical practice. Thus, this work aimed to review the cellular mechanisms through which allicin exerts its therapeutic effects and to show why it could be a therapeutic option for the prevention or treatment of CVD and its risk factors.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Coronary Artery Disease V: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

